Treatment of Substance Use Disorders in Primary Care Webinar Series
Overview: This complimentary, four-part webinar series, funded in part through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care.
Target audience: Primary care providers in rural areas of Wisconsin who receive little support and education for evidence-based treatment of substance use disorders.
AMA Credit Designation Statement: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Participation: Participants may attend any or all of the webinar sessions either in-person during the live presentation, or by viewing the recording on-demand.
Live presentations will be held from 5:30-6:30 pm at Bolz Auditorium at Meriter Hospital in Madison, located in the basement of McConnell Hall. The address is 124. S. Brooks St. Madison, WI 53715.
On-demand webinar recordings will be available online approximately one week after the session has been recorded, and will be linked below.
Part 1: Suboxone 2.0: Beyond the Basics, presented by Ritu Bhatnagar, MD and John Ewing, MD
Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.
Recording date: June 20, 2018
View Webinar | Complete Post-Test to claim CME
Part 2: Interpretation of Urine Drug Screen, presented by David Galbis-Reig, MD
Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.
Recording date: July 18, 2018
On-demand webinar link will be available after August 1, 2018
Part 3: Treatment of Stimulant Disorder, presented by Mark Lim, MD
Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder.
Recording Date: August 15, 2018
Part 4: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD
Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.
Recording Date: October 17, 2018